漆皮 추출물의 담도암 세포주 SNU-1079와 SNU-1196에 대한 항암효과
Study on Anti-Cancer Effects of Rhus Verniciflua Stokes Extracted with Sterile Distilled Water on Two Cholangiocarcinoma Cell Lines, SNU-1079 and SNU-1196
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives: This study was performed to investigate the anti-cancer effects of Rhus verniciflua Stokes (RVS) extracted with sterile distilled water on cholangiocarcinoma cell lines. Materials and Methods: Two cholangiocarcinoma cell lines, SNU-1079 and SNU-1196, were used in this study. Cells were treated with different concentrations of RVS for 24, 48, and 72 hours. Cell count, viability, apoptosis, and mRNA expression of Bax, Bcl-2, Mcl-1, survivin, caspase-3, and cyclin D1 and P21 were determined with an automatic cell counter (ADAM-MC), MTT assay, apoptosis assay (Annexin-V/PI staining), and RT-PCR. Results: All cells treated with RVS showed decreased cell counts in a dose-dependent manner. RVS inhibited proliferation of SNU-1196 in a dose-dependent manner, but SNU-1079 proliferation was inhibited in the long-time culture group in a dose-dependent manner. The proportion of early and late-stage apoptotic cells was increased by RVS in a dose-dependent manner in SNU-1196. In contrast, it was increased significantly in SNU-1079 treated with high-dose RVS. After treatment with RVS, the mRNA expression of Bcl-2 was decreased while Bax was increased in SNU-1079. Cyclin D1 mRNA levels were decreased in SNU-1196 in a dose-dependent manner. P21 expression was increased in all cells after the treatment with RVS. Conclusions: RVS appears to have potential as a therapeutic agent for cholangiocarcinoma.
Abstract
Objectives: This study was performed to investigate the anti-cancer effects of Rhus verniciflua Stokes (RVS) extracted with sterile distilled water on cholangiocarcinoma cell lines. Materials and Methods: Two cholangiocarcinoma cell lines, SNU-1079 and SNU-1196, were used in this study. Cells were treated with different concentrations of RVS for 24, 48, and 72 hours. Cell count, viability, apoptosis, and mRNA expression of Bax, Bcl-2, Mcl-1, survivin, caspase-3, and cyclin D1 and P21 were determined with an automatic cell counter (ADAM-MC), MTT assay, apoptosis assay (Annexin-V/PI staining), and RT-PCR. Results: All cells treated with RVS showed decreased cell counts in a dose-dependent manner. RVS inhibited proliferation of SNU-1196 in a dose-dependent manner, but SNU-1079 proliferation was inhibited in the long-time culture group in a dose-dependent manner. The proportion of early and late-stage apoptotic cells was increased by RVS in a dose-dependent manner in SNU-1196. In contrast, it was increased significantly in SNU-1079 treated with high-dose RVS. After treatment with RVS, the mRNA expression of Bcl-2 was decreased while Bax was increased in SNU-1079. Cyclin D1 mRNA levels were decreased in SNU-1196 in a dose-dependent manner. P21 expression was increased in all cells after the treatment with RVS. Conclusions: RVS appears to have potential as a therapeutic agent for cholangiocarcinoma.
참고문헌 (25)
- DeOliveira ML, "Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution", Ann Surg, 245, pp.755~762 (2007)
- "중앙행정기관-보건복지부-통계 발간물-주제별-질병/건강-국가암 등록사업 연례보고서(2010년 암등록통계)" (2014)[URL]
- Blechacz BG, "Sleisenger and Fordtran’s gastrointestinal and liver disease, Volume 1. 9th ed", pp.1171~1176 (2010), Saunders
- Aljiffry M, "Advances in diagnosis, treatment and palliation of cholangiocarcinoma 1990-2009", World Journal of Gastroenterology, 15, pp.4240~4262 (2009)
- Son YO, "Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines", Toxicology Letters, 155(1), pp.115~125 (2005)
- Jang HS, "Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells", Biochimica et Biophysica Acta, 1726(3), pp.309~316 (2005)
- Samoszuk M, "The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts", BMC Complementary and Alternative Medicine, 5(5) (2005)
- Lee JC, "Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells", Food and Chemical Toxicology, 42(9), pp.1383~1388 (2004)
- 지형준, "대한약전 및 대한약전외 한약규격주해" (1998), 한국메디칼인덱스사
- 송창훈, "원위부 담도암 환자 증례 보고", 대한한방내과학회지, 27(3), pp.771~776 (2006), 대한한방내과학회
- 이경욱, "茵蔯의 에탄올 추출물이 담도암 세포주 SNU-1196의 apoptosis에 미치는 효과에 관한 연구", 대한한방내과학회지, 33(4), pp.587~598 (2012), 대한한방내과학회
- 박진규, "담관암세포주에서 地楡 에탄올 추출물의 항암 효과", 대한한방내과학회지, 33(4), pp.465~475 (2012), 대한한방내과학회
- Lee JO, "Rhus verniciflua Extract Modulates Survival of MCF-7 Breast Cancer Cells through the Modulation of AMPK-Pathway", Biological & Pharmaceutical Bulletin, 37(5), pp.794~801 (2014)
- Lee JC, "Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells", Food and Chemical Toxicology, 42, pp.1383~1388 (2004)
- Junttila MR, "Influence of tumour micro-environment heterogeneity on therapeutic response", Nature, 501, pp.346~354 (2013)
- Sirica AE, "The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma", Nature Reviews Gastroenterology & Hepatology, 9, pp.44~54 (2012)
- Kalluri R, "Fibroblasts in cancer", Nature Reviews Cancer, 6, pp.392~401 (2006)
- Nguyen M, "Human endothelial gelatinases and angiogenesis", International Journal of Biochemistry and Cell Biology, 33(10), pp.960~970 (2001)
- Moon G, "Effect of allergen removed Rhus verniciflua extract on inhibition of tumor metastasis", Journal of Korean Traditional Oncology, 15(1), pp.47~61 (2010)
- 김준식, "식물 추출물의 혈관신생 억제 효능 검색", 생약학회지, 37(4), pp.253~257 (2006), 한국생약학회
- 정성훈, "담관암세포주에서 내인성 peroxisome proliferator-activated receptor gamma 배위자인 15-deoxy-delta(12,14)-prostaglandin J2의 항암 효과", 대한내과학회지, 78(1), pp.75~86 (2010), 대한내과학회
- Oltvai ZN, "Bcl-2heterodimerizes in vivo with a conserved homolog, Bax that accelerates programmed cell death", Cell press, 74(4), pp.609~619 (1993)
- Tamm I, "IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas(CD95), Bax, caspases, and anticancer drugs", Cancer Research, 58(23), pp.5315~5320 (1998)
- Hardwick JM, "Cyclin' on the viral path to destruction", Nature Cell Biology, 2(11), pp.E203~E204 (2000)
- Kufe DW, "Cancer medicine 6" (2003), BC Decker
